𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth Hormone Increases Bone Mineral Content in Postmenopausal Osteoporosis: A Randomized Placebo-Controlled Trial

✍ Scribed by Kerstin Landin-Wilhelmsen; Anders Nilsson; Ingvar Bosaeus; Bengt-Åke Bengtsson

Book ID
111487273
Publisher
American Society for Bone and Mineral Research
Year
2003
Tongue
English
Weight
189 KB
Volume
18
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of nonrandomized trials with
Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis
✍ Dr. Charles Y.C. Pak; Khashayar Sakhaee; Norman H. Bell; Angelo Licata; Conrad J 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 786 KB

The results of slow-release sodium fluoride (SR-NaF) treatment in two nonrandomized trials involving 65 patients with postmenopausal osteoporosis from the primary site and 121 patients from collaborative sites were compared with those obtained from 54 treated patients and 56 patients taking placebo

Alendronate improves bone mineral densit
Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo-controlled trial
✍ Claudia O. Zein; Roberta A. Jorgensen; Bart Clarke; Doris E. Wenger; Jill C. Kea 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Bone loss is a well-recognized complication of primary biliary cirrhosis (PBC). Although it has been suggested that alendronate might improve bone mineral density (BMD) in PBC, no randomized placebo-controlled trial has been conducted. The primary aim of this study was to compare the effects of alen